Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

Author's Avatar
May 31, 2023

Astria+Therapeutics%2C+Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Jefferies Healthcare Conference on Wednesday, June 7th at 2:00pm ET in New York, NY.